Table 5.
Conditional logistic regression model for acute kidney injury
| Category (n = 357 pairs) | 95% Confidence Interval |
||
|---|---|---|---|
| Odds Ratio AKI | Odds Ratio R | Odds Ratio I and F | |
| Age (years) | 0.81 (0.75 to 0.88)a | 0.8 (0.74 to 0.87)a | 0.97 (0.74 to 1.3) |
| SCr values per admit day | 11.9 (4.8 to 29.4)a | 8.3 (3.3 to 21)a | 39.4 (2.3 to 678)a |
| Baseline eCCl (ml/min per 1.73 m2) | 1.01 (1.01 to 1.02)a | 1.01 (1.01 to 1.02)a | 1.03 (1.01 to 1.05)a |
| Acyclovir | 1.7 (0.59 to 5.0) | ||
| Amikacin | |||
| Amphotericin | 9.9 (0.55 −179.8) | ||
| Cefotaxime | 1.7 (0.75 to 3.7) | 2.8 (0.33 to 24.4) | |
| Ceftazidime | 0.6 (0.36 to 1.05) | 1.3 (0.31 to 5.2) | |
| Cisplatin | 1.1 (0.4 to 2.8) | 1.1 (0.42 to 3.0) | |
| Colestimethate | 5.9 (1.0 to 35.2) | 3.1 (0.7 to 13.6) | |
| Ganciclovir | 9.7 (0.69 to 135) | ||
| Gentamicin | 1.8 (0.95 to 3.6) | 4.5 (0.9 to 22.9) | |
| Ifosfamide | 0.3 (0.09 to 1.1) | ||
| Ketorolac | 0.4 (0.13 to 1.2) | ||
| Methotrexate | 2.6 (0.2 to 32.6) | ||
| Naproxen | 11 (0.99 to 122) | ||
| Piperacillin with/without tazobactam | 1.3 (0.6 to 2.5) | 1.2 (0.6 to 2.4) | 12.7 (1.6 to 99.6)a |
| Ticarcillin/clavulanate | 0.6 (0.3 to 1.2) | ||
| Tobramycin | 2.6 (0.7 to 9.2) | ||
| Trimethoprim/sulfamethoxazole | 0.97 (0.6 to 1.6) | 3.3 (0.57 to 19.4) | |
| Vancomycin | 1.9 (1.1 to 3.5)a | 1.8 (1.1 to 3.2)a | 0.76 (0.14 to 4.1) |
a
P < 0.05.